⏳ Fetching live dividend data...
Home › Calculator › GNBT Dividend Calculator 2026
Generex Biotechnology Corporation · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in GNBT → $1.698596171385972e+33M in 10 years · $141,507,228,780,196,900,000,000,000,000,000,000,000.00/month
Founded in 1983 and headquartered in Miramar, Florida, Generex Biotechnology Corporation initially specialized in the delivery of large molecule drugs into the oral cavity via a portable aerosol applicator for use in Canada and the United States, notably offering Generex Oral-lyn, an oral insulin product. The company also had a significant focus on oncology, developing AE37, a synthetic peptide vaccine that had completed Phase IIb clinical trials aimed at stimulating a potent and specific immune response against HER-2/neu oncogenes in breast and prostate cancer patients. Beyond therapeutics, Generex was involved in the development, manufacturing, and distribution of rapid point-of-care in-vitro medical diagnostics for a spectrum of infectious diseases, including HIV, tuberculosis, malaria, and hepatitis, providing both test kits and cassettes. Its product portfolio further included Excellagen, a wound-conforming gel. The company's research and development efforts also extended to immunotherapeutic products, additional vaccines, and an extracellular matrix hydrogel solution designed for the treatment of Ulcerative Colitis. In addition, Generex manufactured and sold specialized surgical kits for foot and ankle procedures, containing plates, screws, and tools, and distributed a wide array of surgical supplies, orthopedic implants, artificial joints, biologics, medical devices, and regenerative medicine products. The corporation also acted as the general partner for a Management Services Organization. However, on April 23, 2022, an involuntary petition for Chapter 7 liquidation was filed against Generex Biotechnology Corporation in the U.S. Bankruptcy Court for the Southern District of Florida, which was subsequently approved by the court on June 6, 2022.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GNBT position with:
Real after-tax yield depends on where you live and how you hold GNBT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 333333.33% | 333330.53% | $33,333,333 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 283333.33% | 283330.53% | $28,333,333 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 266666.66% | 266663.86% | $26,666,666 / yr |
| 🇬🇧 UK ISA | 0% | 333333.33% | 333330.53% | $33,333,333 / yr |
| 🇬🇧 UK Taxable | 8.75% | 304166.66% | 304163.86% | $30,416,666 / yr |
| 🇨🇦 TFSA | 0% | 333333.33% | 333330.53% | $33,333,333 / yr |
| 🇨🇦 CA Taxable | 25% | 250000.00% | 249997.20% | $25,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 283333.33% | 283330.53% | $28,333,333 / yr |
| 🇦🇺 AU Taxable | 30% | 233333.33% | 233330.53% | $23,333,333 / yr |
| 🇩🇪 DE Taxable | 26.375% | 245416.66% | 245413.86% | $24,541,666 / yr |
| 🇫🇷 FR Taxable | 30% | 233333.33% | 233330.53% | $23,333,333 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
GNBT pays quarterly — 4 times per year. Next ex-div: TBD.
How GNBT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GNBT sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2018-12-04 | 945 | $2.12 | $2.0K | ||
| Buy | 2018-12-04 | 555 | $2.10 | $1.2K | ||
| Buy | 2018-12-07 | 8,000 | $1.05 | $8.4K | ||
| Buy | 2018-12-07 | 300 | $1.03 | $309.00 | ||
| A-Award | 2018-10-03 | 4,500 | $2.23 | $10.0K | ||
| A-Award | 2018-10-03 | 4,500 | $2.23 | $10.0K | ||
| A-Award | 2018-10-03 | 1,000 | $2.23 | $2.2K | ||
| A-Award | 2018-10-03 | 1,000 | $2.23 | $2.2K | ||
| A-Award | 2018-10-03 | 4,500 | $2.23 | $10.0K | ||
| A-Award | 2018-10-03 | 4,500 | $2.23 | $10.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GNBT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Generex Biotechnology Corporation (GNBT) is currently trading at $0.00, trading near its 52-week low. The current dividend yield is 333333.33% based on an annual payout of $2.00 per share.
Generex Biotechnology Corporation (GNBT) is a healthcare stock currently trading at $0.00 with a dividend yield of 333333.33%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever